International Technical Seminar/Workshop "EMS/AHPND: Government, Scientist and Farmer Responses" (FAO TCP/INT/3502)
22-24 June 2015 - Tryp Hotel, Panama City
|
1. |
Presentation 1: FAO efforts on shrimp aquaculture health management including the AHPND International Technical Seminar |
Dr Melba B. Reantaso, FAO |
2. |
Presentation 3: Government actions on EMS/AHPND in Thailand |
Dr Putt Songsangjinda, Department of Fisheries Thailand |
3. |
Presentation 4: Development of a prevention and control program for the Acute Hepatopancreatic Necrosis Disease (AHPND) in OIRSA member countries |
Dr Vielka Morales, OIRSA |
4. |
Presentation 5: Review of vibriosis in shrimp farming prior to EMS and risk management measures |
Dr Celia Lavilla-Pitogo, Philippines |
5. |
Presentation 6: Vibrio parahaemolyticus: genome plasticity, mobile genetic elements and bacteriophage therapy |
Dr Iddya Karunasagar, FAO |
6. |
Presentation 7: Retrospective review of bacterial infections in shrimp in Latin America |
Dr Jorge Cuellar, Panama |
7. |
Presentation 8: Vibrio parahaemolyticus: a versatile pathogen that can adapt to a wide variety of environments |
Dr Iddya Karunasagar, FAO |
8. |
Presentation 9: Solving the mysteries of AHPND and the implications for the business: origins of the chase |
Mr Robins McIntosh, Thailand |
9. |
Presentation 10: Successful and unsuccessful responses to AHPND: Mexican producers' experiences |
Mr Guillermo Portillo, Mexico |
10. |
Presentation 11: Managing intensive systems and water quality in AHPND environment |
Mr Scott Horton, Mexico |
11. |
Presentation 12: Shrimp production, disease impacts and EMS/AHPND contingency plan in Ecuador: private-public sector actions |
Dr Laurence Massaut, Ecuador |
12. |
Presentation 13: Chasing AHPND: working toward a better understanding of contributing factors for the disease |
Dr. Jim Brock, Hawaii |
13. |
Presentation 14: Progress in research on EMS/AHPND |
Prof. Timothy W. Flegel, Thailand |
14. |
Presentation 15: Genomic comparisons between Vibrio parahaemolyticus AHPND positive strains |
Dr Sonia Soto, Mexico |
15. |
Presentation 16: Breeding for disease tolerance/resistance in shrimp: the case of WSSV and TSV |
Dr Marcela Salazar, Colombia |
16. |
Presentation 17: Preliminary results on genetic resistance to AHPND and WSSV in Penaeus (Litopenaeus) vannamei in Mexico: the role of inbreeding |
Dr. Hugo Montaldo, Mexico |
17. |
Presentation 18: Problems other than AHPND in EMS ponds, including the microsporidian Enterocytozoon hepatopenaei EHP |
Dr Timothy W. Flegel, Thailand |
18. |
Presentation 19: Covert Mortality Nodavirus (CMNV): the pathogen, pathogenesis, transmission, distribution, impacts, co-infection with EMS/AHPND |
Dr Huang Jie, China |
19. |
Presentation 20: Good aquaculture and biosecurity practices in shrimp farming |
Dr Pornlerd Chanratchakool, Thailand |
20. |
Presentation 21: Biosecurity risks for the shrimp industry and major challenges including SPF and SPR |
Dr Victoria Alday-Sanz, Spain |
FAO Second International Technical Seminar/Workshop on Acute hepatopancreatic necrosis disease (AHPND):
There is a way forward! (FAO TCP/INT/3501 and TCP/INT/3502)
23-25 June 2016 - Sukosol Hotel, Bangkok, Thailand
|
1. |
Introduction to the Technical Seminar/Workshop and Highlights of the Panama Workshop (June 2015) |
Dr Melba B. Reantaso, FAO |
2. |
Presentation 1.1 Basic pond management to reduce current disease risks |
Dr Pornlerd Chanratchakool |
3. |
Presentation 1.2 New paradigm for controlling AHPND in intensive culture systems: what works, what doesn't and why |
Mr David Kawahigashi |
4. |
Presentation 1.3 Living with AHPND: an Asian experience |
Mr Mati Nitibhon |
5. |
Presentation 1.4 The industry response to AHPND in Mexico: a case study |
Mr Dan Fegan |
6. |
Presentation 1.5 Infection trials with both AHPND and EHP: a hatchery protocol that can exclude AHPND |
Dr Loc Tran |
7. |
Presentation 1.6 AHPND: Interaction, control and pond management |
Dr Pikul Jiravanichpaisal |
8. |
Presentation 1.7 Transforming farm managers into the "family physicians" of their own ponds |
Dr Grace Chang |
9. |
Presentation 1.8 Surveillance and animal health monitoring, early detection of diseases |
Mr Shuaib T. Muhammad |
10. |
Presentation 2.1 Update June 2016 on AHPND and EHP research in Thailand |
Dr Tim Flegel |
11. |
Presentation 2.2 Polychaetes as a potential risk for shrimp pathogen transmission |
Dr Desrina |
12. |
Presentation 2.3 Heritability, cross-breeding and inbreeding effects on resistance of Penaeus vannamei to AHPND and WSSV in Mexico |
Dr Hector Castillo |
13. |
Presentation 2.4 Genomic analysis of the strains of AHPND-Vp (global) and genomic target |
Dr Bruno Gomez-Gil |
14. |
Presentation 2.5 Ecology, virulence factors and global spread of pathogenic Vibrio parahaemolyticus and related Vibrio spp. |
Dr Iddya Karunasagar |
15. |
Presentation 2.6 Research progress and biosecurity control strategies against EHP and AHPND for shrimp farming in the People's Republic of China |
Dr Huang Jie |
16. |
Presentation 2.7 Epidemiology of AHPND: experiences in Viet Nam and Thailand |
Dr Visanu Boonyawiwat |
17. |
Presentation 2.8 Characterization of non-Vibrio bacteria as potential associates of AHPND bacteria in Penaeus vannamei |
Dr Kallaya Sritunyalucksana |
18. |
Presentation 2.10 Latest research on AHPND and measures to combat it |
Dr Ikuo Hirono |
19. |
Presentation 2.11 Specific pathogen-free (SPF), specific pathogen-resistant (SPR) and specific pathogen-tolerant (SPT) as part of a biosecurity strategy |
Dr Victoria Alday-Sanz |
20. |
Presentation 3.1 Global production and trade in shrimp and risks of pathogen transfer |
Dr Rohana Subasinghe |
21. |
Presentation 3.2 Aquaculture biosecurity challenges in the light of the Ballast Water Management Convention |
Dr Guillaume Drillet |
22. |
Presentation 3.3 Dealing with AHPND: Viet Nam experience |
Dr Dang Thi Lua |
23. |
Presentation 3.4 Dealing with AHPND: Thailand update from 2015 |
Dr Putth Songsangjinda |
24. |
Presentation 3.6 Avoiding AHPND: Iran experience |
Dr Ghahari and Dr Reza |
25. |
Presentation 3.7 Dealing with shrimp diseases in Brasil (Public Policies for Marine Shrimp Health) |
Dr Rodrigo Roubach and Dr Eduardo Cunha |
26. |
Presentation 3.8 The World Organisation for Animal Health (OIE): relevant activities regarding AHPND |
Prof. Mohammed Shariff |
27. |
Presentation 3.9 Status of AHPND in the NACA/FAO Quarterly Aquatic Animal Disease Reporting System |
Dr Eduardo Leano |
28. |
Presentation 3.10 Progress on AHPND actions in OIRSA countries: 2015 onwards |
Dr Vielka Morales |
29. |
Presentation 3.11 Updates on AHPND in Southeast Asia: outcomes on a recent regional technical consultation on AHPND |
Dr Rolando Pakingking |
30. |
Presentation 3.12 AHPND Contingency Plan under the framework of the Andean Community of Nations (CAN) |
Dr Margy Aliethe Villanueva Soto on behalf of CAN |